Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection
J. Clin. Invest. Feng Lin, et al. 110:1269
doi:10.1172/JCI16086 [Go to this article.]

Problems with a PDF?